<- Go Home

HAEMATO AG

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.

Market Cap

EUR 98.0M

Volume

1.2K

Cash and Equivalents

EUR 13.9M

EBITDA

EUR 9.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 19.7M

Profit Margin

7.56%

52 Week High

EUR 20.80

52 Week Low

EUR 15.00

Dividend

6.40%

Price / Book Value

0.66

Price / Earnings

10.00

Price / Tangible Book Value

1.69

Enterprise Value

EUR 87.2M

Enterprise Value / EBITDA

8.45

Operating Income

EUR 9.2M

Return on Equity

6.51%

Return on Assets

3.22

Cash and Short Term Investments

EUR 13.9M

Debt

EUR 3.1M

Equity

EUR 149.4M

Revenue

EUR 260.8M

Unlevered FCF

EUR 5.0M

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches